{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:03:45Z","timestamp":1783487025094,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.beem.2013.08.008","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T00:02:02Z","timestamp":1378425722000},"page":"233-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Graves' disease in children"],"prefix":"10.1016","volume":"28","author":[{"given":"Juliane","family":"L\u00e9ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentia","family":"Kaguelidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Carel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"9821","key":"10.1016\/j.beem.2013.08.008_bib2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(11)60782-4","article-title":"Thyrotoxicosis","volume":"379","author":"Franklyn","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/eje.0.1300565","article-title":"Incidence of juvenile thyrotoxicosis in Denmark, 1982\u20131988. A nationwide study","volume":"130","author":"Lavard","year":"1994","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2013.08.008_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2265.2009.03717.x","article-title":"Incidence of thyrotoxicosis in childhood: a national population based study in the UK and Ireland","volume":"72","author":"Williamson","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.beem.2013.08.008_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2265.2001.01252.x","article-title":"Increasing incidence of childhood Graves' disease in Hong Kong: a follow-up study","volume":"54","author":"Wong","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.beem.2013.08.008_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/EJE-06-0651","article-title":"Chronic iodine excess does not increase the incidence of hyperthyroidism: a prospective community-based epidemiological survey in China","volume":"156","author":"Yang","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2013.08.008_bib7","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1016\/j.jaci.2009.09.053","article-title":"Immunologic endocrine disorders","volume":"125","author":"Michels","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000313395","article-title":"Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with graves' disease","volume":"73","author":"Wasniewska","year":"2010","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"10.1016\/j.beem.2013.08.008_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1530\/EJE-09-0751","article-title":"Peculiarities of Graves' disease in children and adolescents with Down's syndrome","volume":"162","author":"De Luca","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2013.08.008_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF03346552","article-title":"Graves' disease prevalence in a young population with Turner syndrome","volume":"33","author":"Wasniewska","year":"2010","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"10.1016\/j.beem.2013.08.008_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/thy.1998.8.727","article-title":"What is the evidence of genetic factors in the etiology of Graves' disease? A brief review","volume":"8","author":"Brix","year":"1998","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.beem.2013.08.008_bib12","first-page":"930","article-title":"Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts","volume":"86","author":"Brix","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.beem.2013.08.008_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2010.01.013","article-title":"Genetics of thyroid autoimmunity and the role of the TSHR","volume":"322","author":"Brand","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2013.08.008_bib14","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1210\/en.2005-1024","article-title":"Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model","volume":"147","author":"Saitoh","year":"2006","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.beem.2013.08.008_bib15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/thy.2008.0014","article-title":"Pediatric thyroid-associated orbitopathy: the Children's hospital of Philadelphia experience and literature review","volume":"18","author":"Goldstein","year":"2008","journal-title":"Thyroid"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2013.08.008_bib16","first-page":"234","article-title":"Pediatric aspects in Graves' orbitopathy","volume":"7","author":"Gogakos","year":"2010","journal-title":"Pediatr Endocrinol Rev"},{"issue":"8","key":"10.1016\/j.beem.2013.08.008_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/adc.2003.035980","article-title":"Juvenile thyrotoxicosis; can we do better?","volume":"89","author":"Birrell","year":"2004","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.beem.2013.08.008_bib18","doi-asserted-by":"crossref","first-page":"e616","DOI":"10.1542\/peds.2012-0686","article-title":"Rising serum thyroxine levels and chorea in graves' disease","volume":"131","author":"Leblicq","year":"2013","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.beem.2013.08.008_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1067\/mpd.2000.106219","article-title":"Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease","volume":"137","author":"Lucidarme","year":"2000","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.beem.2013.08.008_bib20","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/jc.2008-0842","article-title":"Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment","volume":"93","author":"Kaguelidou","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib21","first-page":"1719","article-title":"Predictors of early remission of hyperthyroidism in children","volume":"82","author":"Glaser","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2013.08.008_bib22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1210\/jc.2006-1239","article-title":"An optimal treatment for pediatric Graves' disease is radioiodine","volume":"92","author":"Rivkees","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2013.08.008_bib23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/jc.2006-1238","article-title":"The optimal treatment for pediatric Graves' disease is surgery","volume":"92","author":"Lee","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib24","first-page":"310","article-title":"Graves' disease in childhood: advances in management with antithyroid drug therapy","volume":"71","author":"Kaguelidou","year":"2009","journal-title":"Horm Res"},{"issue":"5","key":"10.1016\/j.beem.2013.08.008_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000320028","article-title":"Pediatric Graves' disease: controversies in management","volume":"74","author":"Rivkees","year":"2010","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib26","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1365-2265.2012.04509.x","article-title":"Which antithyroid drug regimen in paediatric Graves' disease?","volume":"77","author":"Schenk","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.beem.2013.08.008_bib27","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1210\/jc.2003-030185","article-title":"Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies","volume":"88","author":"Cooper","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2013.08.008_bib28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.beem.2013.08.008_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4158\/EP.17.3.456","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"17","author":"Bahn","year":"2011","journal-title":"Endocr Pract"},{"issue":"15","key":"10.1016\/j.beem.2013.08.008_bib30","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMc0809750","article-title":"Ending propylthiouracil-induced liver failure in children","volume":"360","author":"Rivkees","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2013.08.008_bib31","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2009-2546","article-title":"Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children","author":"Rivkees","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2013.08.008_bib32","doi-asserted-by":"crossref","first-page":"176970","DOI":"10.1186\/1687-9856-2010-176970","article-title":"Adverse events associated with methimazole therapy of graves' disease in children","volume":"2010","author":"Rivkees","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib33","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease","volume":"92","author":"Nakamura","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2013.08.008_bib34","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1210\/jc.2011-1601","article-title":"Treatment of pediatric Graves' disease is associated with excessive weight gain","volume":"96","author":"van Veenendaal","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2013.08.008_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/jcem-63-1-102","article-title":"Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease","volume":"63","author":"Chen","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2013.08.008_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-12-0507","article-title":"Genes that characterize T3-predominant Graves' thyroid tissues","volume":"168","author":"Matsumoto","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/eje.1.02295","article-title":"Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism?","volume":"155","author":"Laurberg","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2013.08.008_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1210\/jc.2011-1944","article-title":"Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: national long-term cohort study","volume":"97","author":"Leger","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2013.08.008_bib39","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1210\/en.2006-0852","article-title":"Targeting B cells in Graves' disease","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.beem.2013.08.008_bib40","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1210\/jc.2006-2388","article-title":"B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study","volume":"92","author":"El Fassi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2013.08.008_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/clpt.2012.10","article-title":"Autoimmunity and Graves' disease","volume":"91","author":"Bahn","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.beem.2013.08.008_bib42","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/jcem-60-5-1019","article-title":"Management of hyperthyroidism in children and adolescents","volume":"60","author":"Hamburger","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib43","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0031-3955(16)37011-0","article-title":"Hyperthyroidism in children and adolescents","volume":"37","author":"Zimmerman","year":"1990","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"10.1016\/j.beem.2013.08.008_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0929-693X(98)80052-3","article-title":"Maladie de Basedow chez l'enfant: aspects cliniques et \u00e9volutifs","volume":"5","author":"Boiko","year":"1998","journal-title":"Arch Pediatr"},{"issue":"10","key":"10.1016\/j.beem.2013.08.008_bib45","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1210\/jcem.85.10.6922","article-title":"Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients","volume":"85","author":"Lazar","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib46","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/jc.2007-0229","article-title":"Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease","volume":"92","author":"Erbil","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2013.08.008_bib47","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1210\/jc.2008-0660","article-title":"Clinical and economic outcomes of thyroid and parathyroid surgery in children","volume":"93","author":"Sosa","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2013.08.008_bib48","first-page":"212","article-title":"The management of hyperthyroidism in children with emphasis on the use of radioactive iodine","volume":"1","author":"Rivkees","year":"2003","journal-title":"Pediatr Endocrinol Rev"},{"issue":"9","key":"10.1016\/j.beem.2013.08.008_bib49","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1210\/jc.2003-031223","article-title":"A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients","volume":"89","author":"Read","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib50","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1210\/jc.2006-2321","article-title":"Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism","volume":"92","author":"Metso","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2013.08.008_bib51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncpendmet0068","article-title":"Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission?","volume":"2","author":"Weetman","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2013.08.008_bib52","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1542\/peds.65.3.550","article-title":"Remission rates of children and adolescents with thyrotoxicosis treated with antithyroid drugs","volume":"65","author":"Collen","year":"1980","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.beem.2013.08.008_bib53","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1210\/jcem-64-6-1241","article-title":"Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years","volume":"64","author":"Lippe","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2013.08.008_bib54","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/thy.1997.7.755","article-title":"Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy","volume":"7","author":"Shulman","year":"1997","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.beem.2013.08.008_bib55","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1515\/JPEM.1999.12.4.537","article-title":"Factors at onset predictive of lasting remission in pediatric patients with Graves' disease followed for at least three years","volume":"12","author":"Mussa","year":"1999","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2013.08.008_bib56","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1542\/peds.2007-1535","article-title":"Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study","volume":"121","author":"Glaser","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.beem.2013.08.008_bib57","first-page":"1038","article-title":"Age and gender predict the outcome of treatment for Graves' hyperthyroidism","volume":"85","author":"Allahabadia","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2013.08.008_bib58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.0.1470583","article-title":"Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease","volume":"147","author":"Nedrebo","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2013.08.008_bib59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/jc.2002-020389","article-title":"Epitope heterogeneity of thyroid-stimulating antibodies predicts long-term outcome in Graves' patients treated with antithyroid drugs","volume":"88","author":"Kim","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2013.08.008_bib60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.1.02336","article-title":"Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves' disease","volume":"156","author":"Abraham-Nordling","year":"2007","journal-title":"Eur J Endocrinol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X13001310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X13001310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:47:55Z","timestamp":1761497275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X13001310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1521690X13001310"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2013.08.008","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Graves' disease in children","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2013.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}